Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2019. 6 of 11 entries say "Materialised", first in FY2020-Q1. Latest entry: FY2025.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2025MaterialisedAnnual report
「Number of stock acquisition rights (units)* 127,600 [127,600] Class, details and number of shares underlying stock acquisition rights (shares)* Common shares 127,600 [127,600]」
The Company disclosed 127,600 fifth-series stock acquisition rights and 127,600 potential common shares. The exercise period is from 15 January 2027 to 14 January 2035, and the Company recognized ¥4,136 thousand in share-based compensation expense for the fiscal year. - FY2025-H1MaterialisedAnnual report
「Number of stock acquisition rights (units)* 127,600 [127,600] Class, details and number of shares underlying stock acquisition rights (shares)* Common shares 127,600 [127,600] Exercise period for stock acquisition rights* From 17 December 2026 To 16 December 2034」
In respect of the fifth series of stock acquisition rights resolved on 16 December 2024, 127,600 rights and 127,600 common shares were granted. The potential shares arising from stock acquisition rights have been specified. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new businesses or other developments, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The filing states that there was no material change in the risk of dilution of share value from the exercise of stock acquisition rights. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new businesses or other developments, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The filing states that there was no material change in the risk of dilution of share value from the exercise of stock acquisition rights. - FY2022-Q1MaterialisedAnnual report
「1 September 2021–30 November 2021 (Note) 26,400 9,853,520 2,098 551,819 2,098 550,460 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the cumulative first quarter period, exercise of stock acquisition rights increased the number of shares by 26,400, bringing the total number of shares issued and outstanding to 9,853,520. - FY2021Updated the number and ratio of potential sharesAnnual report
「As of 31 October 2021, the end of the month preceding the filing date of this document, the number of potential shares attributable to these stock acquisition rights was 49,300, equivalent to 0.50% of the total 9,853,520 shares issued and outstanding.」
The number of potential shares attributable to stock acquisition rights was updated to 49,300, and the ratio to the total number of shares issued and outstanding was updated to 0.50%. - FY2020Updated the number and ratio of potential sharesAnnual report
「As of 31 October 2020, the end of the month preceding the filing date of this document, the number of potential shares attributable to these stock acquisition rights was 98,720, equivalent to 1.00% of the total 9,827,120 shares issued and outstanding.」
The number of potential shares attributable to stock acquisition rights and its ratio to the total number of shares issued and outstanding were updated. Shares were also issued upon the exercise of stock acquisition rights during the fiscal year. - FY2020-Q3MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
Between 1 March 2020 and 31 May 2020, exercise of stock acquisition rights increased the total number of shares issued and outstanding by 640, bringing the total number of shares issued and outstanding at the period end to 9,824,720. - FY2020-Q2MaterialisedAnnual report
「79,360 9,824,080 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the cumulative second quarter period, exercise of stock acquisition rights increased the total number of shares issued and outstanding by 79,360, resulting in a change in the number of shares related to dilution. - FY2020-Q1MaterialisedAnnual report
「250,080 (Note) Increase resulting from the exercise of stock acquisition rights. Common shares 44,500」
Exercise of stock acquisition rights increased the total number of shares issued and outstanding by 250,080, and an additional 44,500 common shares were newly granted in respect of the fourth series of stock acquisition rights. The disclosure of specific increases in shares and potential shares related to dilution arising from the exercise of stock acquisition rights was updated. - FY2019First statedAnnual report
「As of 31 October 2019, the end of the month preceding the filing date of this document, the number of potential shares attributable to these stock acquisition rights was 173,840, equivalent to 1.8% of the total 9,684,480 shares issued and outstanding.」
The Company quantifies the possibility that exercise of stock acquisition rights granted to directors, officers and employees could dilute existing shareholders' share value and voting rights.